Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon
跳到主要內容
:::
:::

2015

 

  1. Chen JS, Hsu C, Chiang NJ, Tsai CS, Tsou HH, Huang SF, Bai LY, Chang IC, Shiah HS, Ho CL, Yen CJ, Lee KD, Chiu CF, Rau KM, Yu MS, Yang Y, Hsieh RK, Chang JY, Shan YS, Chao Y, Chen LT. A KRAS Mutation Status-Stratified Randomized Phase II Trial of Gemcitabine and Oxaliplatin Alone or in Combination with Cetuximab in Advanced Biliary Tract Cancer. Ann Oncol 2015; 26(5): 943-9. (IF: 7.040; Oncology 18/211)

  2. PDF 下載:Lan YT, Huang KH, Liu CA, Tai LC, Chen MH, Chao Y, Li AF, Chiou SH, Shyr YM, Wu CW, Fang WL*. A Nation-Wide Cancer Registry-Based Study of Adenosquamous Carcinoma in Taiwan. PLoS One 2015; 10(10): e0139748. (IF: 3.234; Multidisciplinary Sciences 9/57)

  3. Chen YY, Li AF, Huang KH, Lan YT, Chen MH, Chao Y, Lo SS, Wu CW, Shyr YM, Fang WL. Adenosquamous Carcinoma of the Stomach and Review of the Literature. Pathol Oncol Res 2015; 21(3): 547-51. (IF: 1.855; Pathology 44/76; Oncology 161/211)

  4. Lin YH, Yen SH, Tsai CC, Kao SC, Lee FL. Adjunctive Orbital Radiotherapy for Ocular Adnexal IgG4-related Disease: Preliminary Experience in Patients Refractory or Intolerant to Corticosteroid Therapy. Ocul Immunol Inflamm 2015; 23(2): 162-7. (IF: 1.972; Ophthalmology 24/57)

  5. Su VY#, Liu CJ#, Hu YW, Su WJ, Chen YM, Lai SL, Chen TJ, Perng DW, Lee YC, Tzeng CH, Chou KT. Amyloidosis and the Risk of Cancer: A Nation-Wide Population-Based Study. Int J Clin Oncol 2015; 20(6): 1244-51. (IF: 2.128; Oncology 146/211)

  6. Hu LY, Ku FC, Wang YP, Shen CC, Hu YW, Yeh CM, Chen PM, Chiang HL, Lu T, Chen TJ, Teng CJ, Liu CJ*. Anxiety and Depressive Disorders among Patients with Esophageal Cancer in Taiwan: A Nation-Wide Population-Based Study. Support Care Cancer 2015; 23(3): 733-40. (IF: 2.364; Rehabilitation 10/65; Health Care Sciences & Services 26/88; Oncology 130/211)

  7. PDF下載:Liu CJ, Chou YJ, Teng CJ, Lin CC, Lee YT, Hu YW, Yeh CM, Chen TJ, Huang N*. Association of Surgeon Volume and Hospital Volume with the Outcome of Patients Receiving Definitive Surgery for Colorectal Cancer: A Nation-Wide Population-Based Study. Cancer 2015; 121(16): 2782-90. (IF: 5.068; Oncology 32/211)

  8. Yang CH, Lin YT, Hung YH, Liao JW, Peir JJ, Liu HM, Lin YL, Liu YM, Chen YW, Chuang KS, Chou FI. Autoradiographic and Histopathological Studies of Boric Acid-Mediated BNCT in Hepatic VX2 Tumor-Bearing Rabbits: Specific Boron Retention and Damage in Tumor and Tumor Vessels. Appl Radiat Isot 2015; 106(): 176-80. (IF: 1.231; Nuclear Science & Technology 8/34; Chemistry, Inorganic & Nuclear 30/45; Radiology, Nuclear Medicine & Medical Imaging 90/125)

  9. Liu YW, Chan CT, Yeh LY, Wang LW, Lin TY. BNCT Treatment Planning for Superficial and Deep-Seated Tumors: Experience from Clinical Trial of Recurrent Head and Neck Cancer at THOR. Appl Radiat Isot 2015; 106(): 121-4. (IF: 1.231; Nuclear Science & Technology 8/34; Chemistry, Inorganic & Nuclear 30/45; Radiology, Nuclear Medicine & Medical Imaging 90/125)

  10. Chen LJ, Lai IC, Wong TT, Lin SC, Ho DM, Chang KP, Guo WY, Yen SH, Chen MT, Chen YW. Can Mixed Pure Hepatocellular Carcinoma and Germinoma Arise together in the Brain? J Chin Med Assoc 2015; 78(9): 562-6. (IF: 0.845; Medicine, General & Internal 106/154)

  11. PDF下載:Chen KF, Yen CC, Lin JK, Chen WS, Yang SH, Jiang JK, Lan YT, Lin CC, Yu HC, Hsu HM, Lin WL, Teng HW*. Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A) is an Independent Prognostic Marker in Wild-Type KRAS Metastatic Colorectal Cancer after Colorectal Liver Metastasectomy. BMC Cancer 2015; 15(): 301. (IF: 3.362; Oncology 81/211)

  12. Liu WH, Chen MT, Wang ML, Lee YY, Chiou GY, Chien CS, Huang PI, Chen YW, Huang MC, Chiou SH, Shih YH, Ma HI. Cisplatin-Selected Resistance is Associated with Increased Motility and Stem-Like Properties via Activation of STAT3/Snail Axis in Atypical Teratoid/Rhabdoid Tumor Cells. Oncotarget 2015; 6(3): 1750-68. (IF: 6.359; Oncology 21/211; Cell Biology 35/184)

  13. Su CY, Lin TC, Lin YF, Chen MH, Lee CH, Wang HY, Lee YC, Liu YP, Chen CL*, Hsiao M*. DDX3 as a Strongest Prognosis Marker and Its Downregulation Promotes Metastasis in Colorectal Cancer. Oncotarget 2015; 6(21): 18602-12. (IF: 6.359; Oncology 21/211; Cell Biology 35/184)

  14. Lee IC, Chen YT, Chao Y, Huo TI, Li CP, Su CW, Lin HC, Lee FY, Huang YH. Determinants of Survival After Sorafenib Failure in Patients With BCLC-C Hepatocellular Carcinoma in Real-World Practice. Medicine (Baltimore) 2015; 94(14): e688. (IF: 5.723; Medicine, General & Internal 15/154)

  15. Li JJ, Lan KL, Chang SF, Chen YF, Tsai WC, Chiang PH, Lin MH, Fischer WB, Shih YS, Yen SH, Liu RS, Tsay YG, Wang HE, Chang CA. Development and Characterization of the Recombinant Human VEGF-EGF Dual-Targeting Fusion Protein as a Drug Delivery System. Bioconjugate Chem 2015; 26(12): 2481-96. (IF: 4.513; Chemistry, Organic 8/58; Biochemical Research Methods 12/79; Chemistry, Multidisciplinary 28/157; Biochemistry & Molecular Biology 62/290)

  16. Huang LC, Chuang H, Kapoor M, Hsieh CY, Chou SC, Lin HH, Chen YW, Chang CC, Hwu JR, Liang YC, Hsu MH. Development of Nordihydroguaiaretic Acid Derivatives as Potential Multidrug-Resistant Selective Agents for Cancer Treatment. RSC Adv 2015; 5(130): 107833-8. (IF: 3.840; Chemistry, Multidisciplinary 33/157)

  17. Chien SH#, Liu CJ#, Hong YC, Teng CJ, Hu YW, Ku FC, Yeh CM, Chiou TJ, Gau JP*, Tzeng CH. Development of Second Primary Malignancy in Patients with non-Hodgkin Lymphoma: A Nation-Wide Population-Based Study. J Cancer Res Clin Oncol 2015; 141(11): 1995-2004. (IF: 3.081; Oncology 90/211)

  18. Lai IC, Shih PH, Yao CJ, Yeh CT, Wang-Peng J, Lui TN, Chuang SE, Hu TS, Lai TY, Lai GM. Elimination of Cancer Stem-Like Cells and Potentiation of Temozolomide Sensitivity by Honokiol in Glioblastoma Multiforme Cells. PLoS One 2015; 10(3): e0114830. (IF: 3.234; Multidisciplinary Sciences 9/57)

  19. Wang JP, Wu CY, Yeh YC, Shyr YM, Wu YY, Kuo CY, Hung YP, Chen MH, Lee WP, Luo JC, Chao Y, Li CP. Erlotinib is Effective in Pancreatic Cancer with Epidermal Growth Factor Receptor Mutations: A Randomized, Open-Label, Prospective Trial. Oncotarget 2015; 6(20): 18162-73. (IF: 6.359; Oncology 21/211; Cell Biology 35/184)

  20. Liu YK, Chen KH, Leu YL, Way TD, Wang LW, Chen YJ, Liu YM. Ethanol Extracts of Cinnamomum Kanehirai Hayata Leaves Induce Apoptosis in Human Hepatoma Cell Through Caspase-3 Cascade. OncoTargets Ther 2015; 8(): 99-108. (IF: 2.311; Biotechnology & Applied Microbiology 76/163; Oncology 137/211)

  21. Lee YY, Yang YP, Huang PI, Li WC, Huang MC, Kao CL, Chen YJ, Chen MT. Exercise Suppresses COX-2 Pro-Inflammatory Pathway in Vestibular Migraine. Brain Res Bull 2015; 116(): 98-105. (IF: 2.718; Neurosciences 134/252)

  22. Hung GY* Yen HJ, Yen CC, Chen WM, Chen PC, Wu HT, Chiou HJ, Chang WH, Hsu HE. Experience of Pediatric Osteosarcoma of the Extremity at a Single Institution in Taiwan: Prognostic Factors and Impact on Survival. Ann Surg Oncol 2015; 22(4): 1080-7. (IF: 3.930; Surgery 15/198; Oncology 63/211)

  23. Chen SC, Chen MH, Li CP, Chen MH, Chang PM, Liu CY, Tzeng CH, Liu YM, Yen SH, Chao Y, Huang PI. External Beam Radiation Therapy with or without Concurrent Chemotherapy for Patients with Unresectable Locally Advanced Hilar Cholangiocarcinoma. Hepato-Gastroenterol 2015; 62(137): 102-7. (IF: 0.928; Surgery 145/197; Gastroenterology & Hepatology 70/76)

  24. Wong TT, Liu YL, Ho DM, Chang KP, Liang ML, Chen HH, Lee YY, Chang FC, Lin SC, Hsu TR, Chen KW, Kwang WK, Hou WY, Wang CY, Yen SH, Guo WY, Chen YW. Factors Affecting Survival of Medulloblastoma in Children: The Changing Concept of Management. Childs Nerv Syst 2015; 31(10): 1687-98. (IF: 1.114; Surgery 129/197; Pediatrics 82/120; Clinical Neurology 161/192)

  25. Chen CC, You JY, Gau JP, Huang CE, Chen YY, Tsai YH, Chou HJ, Lung J*, Yang MH*. Favorable Clinical Outcome and Unique Characteristics in Association With Twist1 Overexpression in De Novo Acute Myeloid Leukemia. Blood Cancer J 2015; 5(8): e339. (IF: 3.467; Oncology 77/211)

  26. Chien SH#, Liu CJ#, Hu YW, Hong YC, Teng CJ, Yeh CM, Chiou TJ, Gau JP*, Tzeng CH. Frequency of Surveillance Computed Tomography in non-Hodgkin Lymphoma and the Risk of Secondary Primary Malignancies: A Nation-Wide Population-Based Study. Int J Cancer 2015; 137(3): 658-65. (IF: 5.085; Oncology 31/211)

  27. Hsieh JC, Hsu CL, Ng SH, Wang CH, Lee KD, Lu CH, Chang YF, Hsieh RK, Yeh KH, Hsiao CH, Chen SY, Shiau CY, Wang HM. Gemcitabine Plus Cisplatin for Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma in Taiwan: A Multicenter Prospective Phase II Trial. Jpn J Clin Oncol 2015; 45(9): 819-27. (IF: 2.016; Oncology 151/211)

  28. Chen MH, Kuo YJ, Yeh YC, Lin YC, Tzeng CH, Liu CY, Chang PM, Chen MH, Jeng YM, Chao Y. High Neuroendocrine Component is a Factor for Poor Prognosis in Gastrointestinal High-Grade Malignant Mixed Adenoneuroendocrine Neoplasms. J Chin Med Assoc 2015; 78(8): 454-9. (IF: 0.845; Medicine, General & Internal 106/154)

  29. Chen MH, Yen CC, Cheng CT, Wu RC, Huang SC, Yu CS, Chung YH, Liu CY, Chang PM, Chao Y, Chen MH, Chen YF, Chiang KC, Yeh TS, Chen TC, Huang CY*, Yeh CN*. Identification of SPHK1 as a Therapeutic Target and Marker of Poor Prognosis in Cholangiocarcinoma. Oncotarget 2015; 6(27): 23594-608. (IF: 6.359; Oncology 21/211; Cell Biology 35/184)

  30. Yang WH, Su YH, Hsu WH, Wang CC, Arbiser JL, Yang MH. Imipramine Blue Halts Head and Neck Cancer Invasion Through Promoting F-Box and Leucine-Rich Repeat Protein 14-Mediated Twist1 Degradation. Oncogene 2015; : 1-12. (IF: 8.459; Oncology 13/211; Genetics & Heredity 12/167; Biochemistry & Molecular Biology 23/290; Cell Biology 26/184)

  31. Chen CY#, Liu CJ#, Feng JY, Loong CC, Liu C, Hsia CY, Hu LY, Lin NC, Hu YW, Yeh CM, Chen TJ, Yang CC*. Incidence and Risk Factors for Tuberculosis After Liver Transplantation in an Endemic Area: A Nation-Wide Population-Based Matched Cohort Study. Am J Transplant 2015; 15(8): 2180-7. (IF: 5.683; Surgery 4/197; Transplantation 2/25)

  32. Liu YC, Chien SH, Fan NW, Hu MH, Gau JP, Liu CJ, Yu YB, Liu CY, Hsiao LT, Liu JH, Chiou TJ, Chen PM, Tzeng CH. Incidence and Risk Factors of Probable and Proven Invasive Fungal Infection in Adult Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation. J Microbiol Immunol Infect 2015; : 1-8. (IF: 2.349; Microbiology 69/119; Infectious Diseases 47/78; Immunology 95/148)

  33. Fang WL, Hung YP, Liu CJ*, Lan YT, Huang KH, Chen MH, Lo SS, Shyr YM, Wu CW, Yang MH, Chen TJ, Chao Y*. Incidence of and Risk Factors for Tuberculosis (TB) in Gastric Cancer Patients in an Area Endemic for TB: A Nation-Wide Population-Based Matched Cohort Study. Medicine (Baltimore) 2015; 94(47): e2163. (IF: 5.723; Medicine, General & Internal 15/154)

  34. Lee YT, Liu CJ*, Hu YW, Teng CJ, Tzeng CH, Yeh CM, Chen TJ, Lin JK, Lin CC, Lan YT, Wang HS, Yang SH, Jiang JK, Chen WS, Lin TC, Chang SC, Chen MH, Teng HW, Liu JH, Yen CC*. Incidence of Second Primary Malignancies Following Colorectal Cancer: A Distinct Pattern of Occurrence Between Colon and Rectal Cancers and Association of Co-Morbidity with Second Primary Malignancies in a Population-Based Cohort of 98,876 Patients in Taiwan. Medicine (Baltimore) 2015; 94(26): e1079. (IF: 5.723; Medicine, General & Internal 15/154)

  35. Hung GY, Yen CC*, Horng JL, Liu CY, Chen WM, Chen TH, Liu CL. Incidences of Primary Soft Tissue Sarcoma Diagnosed on Extremities and Trunk Wall: A Population-Based Study in Taiwan. Medicine (Baltimore) 2015; 94(41): e1696. (IF: 5.723; Medicine, General & Internal 15/154)

  36. Liu CJ, Hu LY, Yeh CM, Hu YW, Chen PM, Chen TJ, Lu T. Irritable Brain Caused by Irritable Bowel? A Nation-Wide Analysis for Irritable Bowel Syndrome and Risk of Bipolar Disorder. PLoS One 2015; 10(3): e0118209. (IF: 3.234; Multidisciplinary Sciences 9/57)

  37. Feng JY, Chen SC, Lee MC, Fan WC, Su WJ, Hu YW, Yeh CM, Chen TJ, Liu CJ*. Is 1-year Follow-Up Adequate for Adult Tuberculosis Contacts? Eur Resp J 2015; 45(5): 1501-4. (IF: 7.636; Respiratory System 4/58)

  38. Chien CS, Wang ML, Chu PY, Chang YL, Liu WHu, Yu CC, Lan YT, Huang PI, Lee YY, Chen YW, Lo WL, Chiou SH. Lin28B/Let-7 Regulates Expression of Oct4 and Sox2 and Reprograms Oral Squamous Cell Carcinoma Cells to a Stem-Like State. Cancer Res 2015; 75(12): 2553-65. (IF: 9.329; Oncology 11/211)

  39. Wu CY, Hsiao LT, Chiou TJ, Gau JP, Liu JH, Yu YB, Wu YT, Liu CJ, Huang YC, Hung MH, Chen PM, Huang YH*, Tzeng CH*. Lymphocyte/Monocyte Ratio and Cycles of Rituximab-Containing Therapy are Risk Factors for Hepatitis B Virus Reactivation in Patients with Diffuse Large B-cell Lymphoma and Resolved Hepatitis B. Leuk Lymphoma 2015; 56(8): 2357-64. (IF: 2.891; Hematology 29/68; Oncology 103/211)

  40. Yang CN, Deng YT, Tang JY, Cheng SJ, Chen ST, Li YJ, Wu TS, Yang MH, Lin BR, Kuo MY, Ko JY, Chang CC*. MicroRNA-29b Regulates Migration in Oral Squamous Cell Carcinoma and Its Clinical Significance. Oral Oncol 2015; 51(2): 170-7. (IF: 3.607; Dentistry, Oral Surgery & Medicine 6/88; Oncology 70/211)

  41. Lu HJ, Yang CC, Wang LW, Chu PY, Tai SK, Chen MH, Yang MH, Chang PM. Modified Weekly Cisplatin-Based Chemotherapy Is Acceptable in Postoperative Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Cancer. Biomed Res Int 2015; 2015(): 307576. (IF: 1.579; Biotechnology & Applied Microbiology 107/163; Medicine, Research & Experimental 85/123)

  42. Yang MY, Chen MT, Huang PI, Wang CY, Chang YC, Yang YP, Lo WL, Sung WH, Liao YW, Lee YY, Chang YL, Tseng LM, Chen YW, Ma HI. Nuclear Localization Signal-Enhanced Polyurethane-Short Branch Polyethylenimine-Mediated Delivery of Let-7a Inhibited Cancer Stem-Like Properties by Targeting the 3'-UTR of HMGA2 in Anaplastic Astrocytoma. Cell Transplant 2015; 24(8): 1431-50. (IF: 3.127; Medicine, Research & Experimental 42/123; Transplantation 10/25; Cell & Tissue Engineering 11/21)

  43. Wang JP, Kao FY, Wu CY, Hung YP, Chao Y, Chou YJ, Li CP. Nucleos(t)ide Analogues Associated With a Reduced Risk of Hepatocellular Carcinoma in Hepatitis B Patients: A Population-Based Cohort Study. Cancer 2015; 121(9): 1446-55. (IF: 5.068; Oncology 32/211)

  44. Liu CJ, Huang N, Lin CC, Lee YT, Hu YW, Yeh CM, Chen TJ, Chou YJ*. Outcome Disparities Between Medical Personnel and Nonmedical Personnel Patients Receiving Definitive Surgery for Colorectal Cancer: A Nation-Wide Population-Based Study. Medicine (Baltimore) 2015; 94(4): e402. (IF: 5.723; Medicine, General & Internal 15/154)

  45. Tsai CH, Lin LT, Wang CY, Chiu YW, Chou YT, Chiu SJ, Wang HE, Liu RS, Wu CY, Chan PC, Yang MH, Chiou SH, Liao MJ, Lee YJ*. Over-Expression of Cofilin-1 Suppressed Growth and Invasion of Cancer Cells is Associated with Up-Regulation of Let-7 MicroRNA. Biochim Biophys Acta 2015; 1852(5): 851-61. (IF: 4.882; Biophysics 12/73; Biochemistry & Molecular Biology 54/290)

  46. Cheng CT, Chu YY, Yeh CN, Huang SC, Chen MH, Wang SY, Tsai CY, Chiang KC, Chen YY, Ma MC, Liu CT, Chen TW, Yeh TS*. Peritumoral SPARC Expression and Patient Outcome with Resectable Intrahepatic Cholangiocarcinoma. OncoTargets Ther 2015; 8(): 1899-907. (IF: 2.311; Biotechnology & Applied Microbiology 76/163; Oncology 137/211)

  47. Fan LC#, Teng HW#, Shiau CW, Tai WT, Hung MH, Yang SH, Jiang JK, Chen KF*. Pharmacological Targeting SHP-1-STAT3 Signaling is a Promising Therapeutic Approach for the Treatment of Colorectal Cancer. Neoplasia 2015; 17(9): 687-96. (IF: 4.252; Oncology 49/211)

  48. Venkatakrishnan K*, Kim TM, Lin CC, Thye LS, Chng WJ, Ma B, Chen MH, Zhou X, Liu H, Kelly V, Kim WS. Phase 1 Study of the Investigational Aurora A Kinase Inhibitor Alisertib (MLN8237) in East Asian Cancer Patients: Pharmacokinetics and Recommended Phase 2 Dose. Invest New Drugs 2015; 33(4): 942-53. (IF: 2.919; Pharmacology & Pharmacy 89/255; Oncology 101/211)

  49. Kao WY, Chao Y, Chang CC, Li CP, Su CW, Huo TI, Huang YH, Chang YJ, Lin HC, Wu JC. Prognosis of Early-Stage Hepatocellular Carcinoma: The Clinical Implications of Substages of Barcelona Clinic Liver Cancer System Based on a Cohort of 1265 Patients. Medicine (Baltimore) 2015; 94(43): e1929. (IF: 5.723; Medicine, General & Internal 15/154)

  50. Liu CJ#, Hong YC#, Teng CJ, Hung MH, Hu YW, Ku FC, Chen YT, Chien SH, Yeh CM, Chen TJ, Chiou TJ, Gau JP*, Tzeng CH. Risk and Impact of Tuberculosis in Patients with Chronic Myeloid Leukemia: A Nation-Wide Population-Based Study in Taiwan. Int J Cancer 2015; 136(8): 1881-7. (IF: 5.085; Oncology 31/211)

  51. Chiang HL, Liu CJ, Hu YW, Chen SC, Hu LY, Shen CC, Yeh CM, Chen TJ, Gau SS*. Risk of Cancer in Children, Adolescents, and Young Adults with Autistic Disorder. J Pediatr 2015; 166(2): 418-23. (IF: 3.790; Pediatrics 6/120)

  52. Lee PC, Hu YW, Hu LY, Chen SC, Chien SH, Shen CC, Yeh CM, Chen CC, Lin HC, Yen SH, Tzeng CH, Chen TJ, Liu CJ*. Risk of Cancer in Patients with Cholecystitis: A Nation-Wide Population-Based Study. Am J Med 2015; 128(2): 185-91. (IF: 5.003; Medicine, General & Internal 18/154)

  53. Hung N, Shen CC, Hu YW, Hu LY, Yeh CM, Teng CJ, Kuan AS, Chen SC, Chen TJ, Liu CJ. Risk of Cancer in Patients with Iron Deficiency Anemia: A Nation-Wide Population-Based Study. PLoS One 2015; 10(3): e0119647. (IF: 3.234; Multidisciplinary Sciences 9/57)

  54. Hu LY, Ku FC, Lu T, Shen CC, Hu YW, Yeh CM, Tzeng CH, Chen TJ, Chen PM, Liu CJ. Risk of Cancer in Patients with Irritable Bowel Syndrome: A Nation-Wide Population-Based Study. Ann Epidemiol 2015; 25(12): 924-28. (IF: 2.000; Public, Environmental & Occupational Health 66/170)

  55. Kuan AS, Chen SC, Yeh CM, Hung MH, Hung YP, Chen TJ, Liu CJ*. Risk of Ischemic Stroke in Patients with Gastric Cancer: A Nation-Wide Population-Based Cohort Study. Medicine (Baltimore) 2015; 94(37): e1336. (IF: 5.723; Medicine, General & Internal 15/154)

  56. Hsiao LT, Chiou TJ, Gau JP, Yang CF, Yu YB, Liu CY, Liu JH, Chen PM, Tzeng CH, Chan YJ, Yang MH, Huang YH*. Risk of Reverse Seroconversion of Hepatitis B Virus Surface Antigen in Rituximab-Treated non-Hodgkin Lymphoma Patients: A Large Cohort Retrospective Study. Medicine (Baltimore) 2015; 94(32): e1321. (IF: 5.723; Medicine, General & Internal 15/154)

  57. Yang SH, Hsiao LT*, Chiou TJ, Yang CF, Yu YB, Liu CY, Gau JP, Liu JH, Chen PM, Tzeng CH. Rituximab Induction Therapy, Survival Benefits, and the Increasing Selection of Radiotherapy as the Postinduction Treatment in Patients with Primary Mediastinal Large B-Cell Lymphoma. J Chin Med Assoc 2015; 78(7): 400-7. (IF: 0.845; Medicine, General & Internal 106/154)

  58. Chen SC, Teng CJ, Hu YW, Yeh CM, Hung MH, Hu LY, Ku FC, Tzeng CH, Chiou TJ, Chen TJ, Liu CJ. Secondary Primary Malignancy Risk among Patients with Esophageal Cancer in Taiwan: A Nation-Wide Population-Based Study. PLoS One 2015; 10(1): e0116384. (IF: 3.234; Multidisciplinary Sciences 9/57)

  59. Teng CJ, Huon LK, Hu YW, Yeh CM, Chao Y, Yang MH, Chen TJ, Hung YP, Liu CJ*. Secondary Primary Malignancy Risk in Patients with Cervical Cancer in Taiwan: A Nation-Wide Population-Based Study. Medicine (Baltimore) 2015; 94(43): e1803. (IF: 5.723; Medicine, General & Internal 15/154)

  60. Hung YP, Liu CJ, Hu YW, Chen MH, Li CP, Yeh CM, Chiou TJ, Chen TJ, Yang MH, Chao Y*. Secondary Primary Malignancy Risk in Patients with Ovarian Cancer in Taiwan: A Nation-Wide Population-Based Study. Medicine (Baltimore) 2015; 94(38): e1626. (IF: 5.723; Medicine, General & Internal 15/154)

  61. Ye BW, Lee KC, Hsieh YC, Li CP, Chao Y, Hou MC, Lin HC. Self-Expandable Metallic Stent Placement in Malignant Gastric Outlet Obstruction: A Comparison Between 2 Brands of Stents. Medicine (Baltimore) 2015; 94(29): e1208. (IF: 5.723; Medicine, General & Internal 15/154)

  62. Yang YH, Teng HW (co-first author), Lai YT, Li SY, Lin CC, Yang AC, Chan HL, Hsieh YH, Lin CF, Hsu FY, Liu CK, Liu WS*. Statins Reduces the Risk of Dementia in Patients with Late-Onset Depression: A Retrospective Cohort Study. PLoS One 2015; 10(9): e0137914. (IF: 3.234; Multidisciplinary Sciences 9/57)

  63. Chien Y, Chang YL, Li HY, Larsson M, Wu WW, Chien CS, Wang CY, Chu PY, Chen KH, Lo WL, Chiou SH, Lan YT, Huo TI, Lee SD, Huang PI. Synergistic Effects of Carboxymethyl-Hexanoyl Chitosan, Cationic Polyurethane-Short Branch PEI in miR122 Gene Delivery: Accelerated Differentiation of iPSCs into Mature Hepatocyte-Like Cells and Improved Stem Cell Therapy in a Hepatic Failure Model. Acta Biomater 2015; 13(): 228-44. (IF: 6.025; Engineering, Biomedical 3/76; Materials Science, Biomaterials 2/33)

  64. Chen PM, Chen SC, Liu CJ, Hung MH, Tsai CF, Hu YW, Chen MH, Shen CC, Su TP, Yeh CM, Lu T, Chen TJ, Hu LY*. The Association Between Prostate Cancer and Mood Disorders: A Nation-Wide Population-Based Study in Taiwan. Int Psychogeriatr 2015; 27(3): 481-90. (IF: 1.934; Gerontology 10/32; Psychology, Clinical 46/119; Psychiatry 59/140; Geriatrics & Gerontology 8/16; Gerontology 8/16; Psychology, Clinical 13/25; Psychology 42/76; Psychiatry 79/140; Psychology 35/61; Geriatrics & Gerontology 29/50)

  65. Chao Y, Chung YH, Han G, Yoon JH, Yang J, Wang J, Shao GL, Kim BI, Lee TY. The Combination of Transcatheter Arterial Chemoembolization and Sorafenib is Well Tolerated and Effective in Asian Patients with Hepatocellular Carcinoma: Final Results of the START Trial. Int J Cancer 2015; 136(6): 1458-67. (IF: 5.085; Oncology 31/211)

  66. Huang KH, Lan YT, Chen MH, Chao Y, Lo SS, Li AF, Wu CW, Chiou SH, Yang MH, Shyr YM, Fang WL*. The Correlation Between RhoA Expression and Clinicopathological Characteristics in Gastric Cancer Patients After Curative Surgery. World J Surg 2015; 39(9): 2289-99. (IF: 2.642; Surgery 47/198)

  67. Tseng CL, Lai WJ, Huang CJ, Huang YH, Su CW, Lee IC, Tseng HS, Li CP, Lee RC, Lin HC, Chao Y. The Effectiveness of ART Score in Selecting Patients for Transarterial Chemoembolization Retreatment: A Cohort Study in Taiwan. Medicine (Baltimore) 2015; 94(47): e1659. (IF: 5.723; Medicine, General & Internal 15/154)

  68. Lu HJ, Lin JK, Chen WS, Jiang JK, Yang SH, Lan YT, Lin CC, Liu CA, Teng HW*. The Prognostic Role of Para-Aortic Lymph Nodes in Patients with Colorectal Cancer: Is It Regional or Distant Disease? PLoS One 2015; 10(6): e0130345. (IF: 3.234; Multidisciplinary Sciences 9/57)

  69. Fang WL*, Huang KH, Lan YT, Chen MH, Chao Y, Lo SS, Wu CW, Shyr YM, Li AF*. The Risk Factors of Lymph Node Metastasis in Early Gastric Cancer. Pathol Oncol Res 2015; 21(4): 941-6. (IF: 1.855; Pathology 44/76; Oncology 161/211)

  70. Lai IC, Wong TT, Shiau CY, Hu YW, Ho DM, Chang KP, Guo WY, Chang FC, Liang ML, Lee YY, Chen HH, Yen SH, Chen YW. Treatment Results and Prognostic Factors for Intracranial Nongerminomatous Germ Cell Tumors: Single Institute Experience. Childs Nerv Syst 2015; 31(5): 683-91. (IF: 1.114; Surgery 129/197; Pediatrics 82/120; Clinical Neurology 161/192)

  71. Chen MH, Chen HA, Chen WS, Chen MH, Tsai CY*, Chou CT*. Upregulation of BMP-2 Expression in Peripheral Blood Mononuclear Cells by Proinflammatory Cytokines and Radiographic Progression in Ankylosing Spondylitis. Mod Rheumatol 2015; 25(6): 913-8. (IF: 2.397; Rheumatology 17/32)

  72. Chien SH, Liu CJ, Hong YC, Teng CJ, Hu YW, Shen CC, Ku FC, Chen SC, Yeh CM, Chiou TJ, Gau JP, Tzeng CH. Use of Azathioprine for Graft-vs-Host Disease is the Major Risk for Development of Secondary Malignancies After Haematopoietic Stem Cell Transplantation: A Nation-Wide Population-Based Study. Br J Cancer 2015; 112(1): 177-84. (IF: 4.836; Oncology 34/211)

  73. 王帝皓, 朱原嘉, 李孝瑞, 李秉倫, 蕭正英. 運用網路應用編程介面整合各放射治療儀並連結醫院資訊系統 Integration Of Records And Verify System Between Vendors And Web Application Programming Interface Set-up: An Approach To Bridging Radiation Oncology And Hospital Information System. 放射治療與腫瘤學 2015 Dec; 22(4): 307-14.

 

 

 

Teng CJ, Hu YW, Chen SC, Yeh CM, Chiang HL, Chen TJ, Liu CJ*. Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy: A Nationwide Population-Based Study. JNCI-Journal of the National Cancer Institute. 2015 Nov 3;108(2). pii: djv314. doi: 10.1093/jnci/djv314. Print 2016 Feb. 2015 Nov. (IF: 12.583; Oncology 8/211; 3.8%) (通訊作者)

B. Refereed Papers Not Included in Science Citation Index:

Chen SC, Yang CW, Yen CC, Tseng CH, Chao TC. Perivascular Epithelioid Cell Tumors (PEComas)  Refractory to mTOR Inhibitors. J. Cancer Res. Pract.1(2), 128-133, 2014

Letter:

Liao TT, Hsu WH, Ho CH, Hwang WL, Lan HY, Lo T, Chang CC, Tai SK, Yang MH*. let-7 modulates chromatin configuration and target gene repression through regulation of the ARID3B complex. Cell Rep 2015 (in press) (*: corresponding author)(2014 IF=8.358, 27/184 of Cell Biology).

最後更新:

回到最上